150 related articles for article (PubMed ID: 9891236)
21. Distribution of HPV infection and tumour markers in cervical intraepithelial neoplasia from cone biopsies of Mozambican women.
Carrilho C; Cirnes L; Alberto M; Buane L; Mendes N; David L
J Clin Pathol; 2005 Jan; 58(1):61-8. PubMed ID: 15623485
[TBL] [Abstract][Full Text] [Related]
22. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
[TBL] [Abstract][Full Text] [Related]
23. Detection of p53 protein and Ki-67 proliferation antigen in human papillomavirus (HPV)-positive and HPV-negative cervical lesions by immunohistochemical double-staining.
Tervahauta AI; Syrjänen SM; Mäntyjärvi R; Syrjänen KJ
Cytopathology; 1994 Oct; 5(5):282-93. PubMed ID: 7819513
[TBL] [Abstract][Full Text] [Related]
24. Decreased expression of human papillomavirus E2 protein and transforming growth factor-beta1 in human cervical neoplasia as an early marker in carcinogenesis.
Torng PL; Chan WY; Lin CT; Huang SC
J Surg Oncol; 2003 Sep; 84(1):17-23. PubMed ID: 12949986
[TBL] [Abstract][Full Text] [Related]
25. High risk HPV and p53 protein expression in cervical intraepithelial neoplasia.
Vassallo J; Derchain SF; Pinto GA; Martinez EZ; Syrjänen KJ; Andrade LA
Int J Gynaecol Obstet; 2000 Oct; 71(1):45-8. PubMed ID: 11044541
[TBL] [Abstract][Full Text] [Related]
26. bcl-2 immunoreactivity, human papillomavirus DNA, and cervical intraepithelial neoplasia.
Cooper K; Haffajee Z; Taylor L
Mod Pathol; 1999 Jun; 12(6):612-7. PubMed ID: 10392638
[TBL] [Abstract][Full Text] [Related]
27. p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
Fulop V; Mok SC; Genest DR; Gati I; Doszpod J; Berkowitz RS
J Reprod Med; 1998 Feb; 43(2):119-27. PubMed ID: 9513873
[TBL] [Abstract][Full Text] [Related]
28. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.
Helland A; Karlsen F; Due EU; Holm R; Kristensen G; Børresen-Dale Al
Br J Cancer; 1998 Jul; 78(1):69-72. PubMed ID: 9662253
[TBL] [Abstract][Full Text] [Related]
30. The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix.
Jones MW; Kounelis S; Papadaki H; Bakker A; Swalsky PA; Finkelstein SD
Int J Gynecol Pathol; 1997 Oct; 16(4):301-6. PubMed ID: 9421067
[TBL] [Abstract][Full Text] [Related]
31. Detection and typing of human papillomavirus in cervical intraepithelial neoplasia grade III in Thai women.
Lertworapreecha M; Bhattarakosol P; Niruthisard S
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):507-11. PubMed ID: 10437947
[TBL] [Abstract][Full Text] [Related]
32. p53 status and human papillomavirus infection in Thai women with cervical carcinoma.
Limpaiboon T; Pooart J; Bhattarakosol P; Niruthisard S; Chantratita W; Lulitanond V
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):66-71. PubMed ID: 11023067
[TBL] [Abstract][Full Text] [Related]
33. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer.
Nindl I; Rindfleisch K; Lotz B; Schneider A; Dürst M
Int J Cancer; 1999 Jul; 82(2):203-7. PubMed ID: 10389753
[TBL] [Abstract][Full Text] [Related]
34. p53 immunostaining and HPV DNA detection by PCR in cervical intraepithelial neoplasia: clinical implications of a combinated evaluation.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; De Nictolis M; Fabris G; Biagini G
Anticancer Res; 1997; 17(1B):555-60. PubMed ID: 9066579
[TBL] [Abstract][Full Text] [Related]
35. p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.
Giannikaki E; Kouvidou C; Tzardi M; Stefanaki K; Koutsoubi K; Gregoriou M; Zois E; Kakolyris S; Mavroudi C; Delides G; Georgoulias V; Kanavaros P
Anticancer Res; 1997; 17(3C):2123-7. PubMed ID: 9216675
[TBL] [Abstract][Full Text] [Related]
36. Correlation of MIB-1 antigen expression with transcription factors Skn-1, Oct-1, AP-2, and HPV type in cervical intraepithelial neoplasia.
Hietala KA; Kosma VM; Syrjänen KJ; Syrjänen SM; Kellokoski JK
J Pathol; 1997 Nov; 183(3):305-10. PubMed ID: 9422986
[TBL] [Abstract][Full Text] [Related]
37. [Association of p16, p53, Ki-67 expressions with high-risk human papilloma virus infection in cervical intraepithelial neoplasia].
Shi J; Zheng JS; Yin F; Hu WW; Huang XJ; Zhou XL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):515-7. PubMed ID: 17545048
[TBL] [Abstract][Full Text] [Related]
38. Characterization of human papillomavirus infection, P53 and Ki-67 expression in cervix cancer of Mozambican women.
Carrilho C; Gouveia P; Cantel M; Alberto M; Buane L; David L
Pathol Res Pract; 2003; 199(5):303-11. PubMed ID: 12908520
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
[TBL] [Abstract][Full Text] [Related]
40. p53, mdm-2, and p21 waf-1 in the porokeratoses.
Nelson C; Cowper S; Morgan M
Am J Dermatopathol; 1999 Oct; 21(5):420-5. PubMed ID: 10535569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]